| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0021764> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0079189> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C1174093> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35361913_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, 142-8666, Japan.\', \'Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, 142-8666, Japan. oldham726@yahoo.co.jp.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Akimoto_Kaho> <https://research.tib.eu/covid-19/entity/Ebato_Takaya> <https://research.tib.eu/covid-19/entity/Fukuda_Yosuke> <https://research.tib.eu/covid-19/entity/Goto_Yuiko> <https://research.tib.eu/covid-19/entity/Homma_Tetsuya> <https://research.tib.eu/covid-19/entity/Ikeda_Hitoshi> <https://research.tib.eu/covid-19/entity/Inoue_Hideki> <https://research.tib.eu/covid-19/entity/Kawahara_Tomoko> <https://research.tib.eu/covid-19/entity/Mikuni_Hatsuko> <https://research.tib.eu/covid-19/entity/Onitsuka_Chisato> <https://research.tib.eu/covid-19/entity/Sagara_Hironori> <https://research.tib.eu/covid-19/entity/Sato_Hiroki> <https://research.tib.eu/covid-19/entity/Sato_Yoko> <https://research.tib.eu/covid-19/entity/Suganuma_Hiromitsu> <https://research.tib.eu/covid-19/entity/Suzuki_Shintaro> <https://research.tib.eu/covid-19/entity/Tanaka_Akihiko> <https://research.tib.eu/covid-19/entity/Uchida_Yoshitaka>
?:doi	10.1038/s41598-022-09544-8
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41598-022-09544-8>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Scientific reports
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35361913>
?:pmid	<https://research.tib.eu/covid-19/entity/35361913>
?:pmid	35361913
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.533
?:rankingScore_hIndex	122
?:title	Serum IL-28A/IFN-λ2 is linked to disease severity of COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35361913>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35361913>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all